The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Mycobacterial lipoarabinomannan: An extraordinary lipoheteroglycan with profound physiological effects
Open accessAbstract
Detailed structural and functional studies over the last decade have led to current recognition of the mycobacterial lipoarabinomannan (LAM) as a phosphatidylinositol anchored lipoglycan with diverse biological activities. Fatty acylation has been demonstrated to be essential for LAM to maintain its functional integrity although the focus has largely been on the arabinan motifs and the terminal capping function. It has recently been shown that the mannose caps may be involved not only in attenuating host immune response, but also in mediating the binding of mycobacteria to and subsequent entry into macrophages. This may further be linked to an intracellular trafficking pathway through which LAM is thought to be presented by CD1 to subsets of T-cells. The implication of LAM as major histocompatibility complex (MHC)-independent T-cell epitope and the ensuing immune response is an area of intensive studies. Another recent focus of research is the biosynthesis of arabinan which has been shown to be inhibitable by the anti-tuberculosis drug, ethambutol. The phenomenon of truncated LAM as synthesized by ethambutol resistant strains provides an invaluable handle for dissecting the array of arabinosyltransferases involved, as well as generating much needed structural variants for further structural and functional studies. It is hoped that with more systematic investigations based on clinical isolates and human cell lines, the true significance of LAM in the immunopathogenesis of tuberculosis and leprosy can eventually be explained.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brennan, P. J., & Nikaido, H. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.000333 · Cited by 1,985
CD1-Restricted T Cell Recognition of Microbial Lipoglycan Antigens
Sieling, P. A., Chatterjee, D., Porcelli, S. A., Prigozy, T. I., Mazzaccaro, R. J., Soriano, T., Bloom, B. R., Brenner, M. B., Kronenberg, M., Brennan, P. J., et al. (1995) · Science · doi:10.1126/science.7542404 · Cited by 740
Self-citationSchlesinger, L. S. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.7.2920 · Cited by 612
Belanger, A. E., Besra, G. S., Ford, M. E., Mikusová, K., Belisle, J. T., Brennan, P. J., & Inamine, J. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11919 · Cited by 466
Chan, J., Fan, X. D., Hunter, S. W., Brennan, P. J., & Bloom, B. R. (1991) · Infection and Immunity · doi:10.1128/iai.59.5.1755-1761.1991 · Cited by 397
The CD1 Family: A Third Lineage of Antigen-Presenting Molecules
Porcelli, S. A. (1995) · Advances in Immunology · doi:10.1016/s0065-2776(08)60629-x · Cited by 385
Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis
Takayama, K., & Kilburn, J. O. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1493 · Cited by 369
Xu, S., Cooper, A., Sturgill-Koszycki, S., van Heyningen, T., Chatterjee, D., Orme, I., Allen, P., & Russell, D. G. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.6.2568 · Cited by 359
Self-citationSchlesinger, L. S., Hull, S. R., & Kaufman, T. M. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.8.4070 · Cited by 353
Prigozy, T. I., Sieling, P. A., Clemens, D., Stewart, P. L., Behar, S. M., Porcelli, S. A., Brenner, M. B., Modlin, R. L., & Kronenberg, M. (1997) · Immunity · doi:10.1016/s1074-7613(00)80425-2 · Cited by 337
Hunter, S. W., Gaylord, H., & Brennan, P. J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67246-1 · Cited by 326
Biogenesis of the mycobacterial cell wall and the site of action of ethambutol
Mikusová, K., Slayden, R. A., Besra, G. S., & Brennan, P. J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2484 · Cited by 301
Barnes, P. F., Chatterjee, D., Abrams, J. S., Lu, S., Wang, E., Yamamura, M., Brennan, P. J., & Modlin, R. L. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.2.541 · Cited by 294
Self-citationLipoarabinomannan of Mycobacterium tuberculosis. Capping with mannosyl residues in some strains.
Chatterjee, D., Lowell, K., Rivoire, B., McNeil, M. R., & Brennan, P. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42686-5 · Cited by 243
Self-citationZhang, Y., Broser, M., Cohen, H., Bodkin, M., Law, K., Reibman, J., & Rom, W. N. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117702 · Cited by 234
Besra, G. S., Khoo, K.-H., McNeil, M. R., Dell, A., Morris, H. R., & Brennan, P. J. (1995) · Biochemistry · doi:10.1021/bi00013a015 · Cited by 232
Self-citationKhoo, K.-H., Dell, A., Morris, H. R., Brennan, P. J., & Chatterjee, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.21.12380 · Cited by 223
Self-citationZhang, Y., Doerfler, M. E., Lee, T. C., Guillemin, B., & Rom, W. N. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116430 · Cited by 219
Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor
Chatterjee, D., Roberts, A. D., Lowell, K., Brennan, P. J., & Orme, I. M. (1992) · Infection and Immunity · doi:10.1128/iai.60.3.1249-1253.1992 · Cited by 218
Self-citationRoach, T. I., Barton, C. H., Chatterjee, D., & Blackwell, J. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.5.1886 · Cited by 215
Self-citationBeckman, E. M., Melián, A., Behar, S. M., Sieling, P. A., Chatterjee, D., Furlong, S. T., Matsumoto, R., Rosat, J. P., Modlin, R. L., & Porcelli, S. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.7.2795 · Cited by 209
Self-citationMcNeil, M. R., & Brennan, P. J. (1991) · Research in Microbiology · doi:10.1016/0923-2508(91)90120-y · Cited by 206
Schlesinger, L. S., Kaufman, T. M., Iyer, S., Hull, S. R., & Marchiando, L. K. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.10.4568 · Cited by 197
Zhang, Y., Broser, M., & Rom, W. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2225 · Cited by 189
Moreno, C., Taverne, J., Mehlert, A., Bate, C., Brealey, R., Meager, A., Rook, G. A. W., & Playfair, J. H. L. (1989) · PubMed Central · Cited by 185
Lipoarabinomannan. Multiglycosylated form of the mycobacterial mannosylphosphatidylinositols.
Chatterjee, D., Hunter, S. W., McNeil, M., & Brennan, P. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42685-3 · Cited by 175
Self-citationBiosynthesis of Mycobacterial Lipoarabinomannan
Besra, G. S., Morehouse, C. B., Rittner, C. M., Waechter, C. J., & Brennan, P. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.29.18460 · Cited by 161
Structural features of the arabinan component of the lipoarabinomannan of Mycobacterium tuberculosis
Chatterjee, D., Bozic, C. M., McNeil, M., & Brennan, P. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92870-x · Cited by 159
Self-citationRecognition of multiple effects of ethambutol on metabolism of mycobacterial cell envelope
Deng, L. L., Mikušová, K., Robuck, K. G., Scherman, M., Brennan, P. J., & McNeil, M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.694 · Cited by 157
Biosynthesis of Mannophosphoinositides by Mycobacterium phlei
Brennan, P. J., & Ballou, C. E. (1967) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)95931-4 · Cited by 146
Structural features of the exocellular polysaccharides of Mycobacterium tuberculosis
Lemassu, A., & Daffé, M. (1994) · Biochemical Journal · doi:10.1042/bj2970351 · Cited by 143
Lee, R. E., Jr., Mikušová, K., Brennan, P. J., & Besra, G. S. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00153a002 · Cited by 140
Khoo, K., Dell, A., Morris, H. R., Breman, P. J., & Chatterjee, D. (1995) · Glycobiology · doi:10.1093/glycob/5.1.117 · Cited by 136
Self-citationTumor necrosis factor production in patients with leprosy
Barnes, P. F., Chatterjee, D., Brennan, P. J., Rea, T. H., & Modlin, R. L. (1992) · Infection and Immunity · doi:10.1128/iai.60.4.1441-1446.1992 · Cited by 135
Self-citationVenisse, A., Berjeaud, J., Chaurand, P., Gilleron, M., & Puzo, G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31404-2 · Cited by 130
Structure and antigenicity of lipoarabinomannan from Mycobacterium bovis BCG
Prinzis, S., Chatterjee, D., & Brennan, P. J. (1993) · Journal of General Microbiology · doi:10.1099/00221287-139-11-2649 · Cited by 130
Self-citationKhoo, K., Douglas, E., Azadi, P., Inamine, J. M., Besra, G. S., Mikušová, K., Brennan, P. J., & Chatterjee, D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.45.28682 · Cited by 108
Self-citationLee, Y. C., & Ballou, C. E. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)91317-7 · Cited by 104
Rastogi, N. (1991) · Research in Microbiology · doi:10.1016/0923-2508(91)90121-p · Cited by 95
Adams, L. B., Fukutomi, Y., & Krahenbuhl, J. L. (1993) · Infection and Immunity · doi:10.1128/iai.61.10.4173-4181.1993 · Cited by 93
Chatterjee, D., Khoo, K., McNeil, M., Dell, A., Morris, H. R., & Brennan, P. J. (1993) · Glycobiology · doi:10.1093/glycob/3.5.497 · Cited by 82
Self-citationYoshida, A., & Koide, Y. (1997) · Infection and Immunity · doi:10.1128/iai.65.5.1953-1955.1997 · Cited by 66
Peterson, P. K., Hu, S., Sheng, W., Kravitz, F. H., Molitor, T. W., Chatterjee, D., & Chao, C. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/172.4.1137 · Cited by 63
Self-citationAntigen presentation by CD1 and MHC-encoded class I-like molecules
Melián, A., Beckman, E. M., Porcelli, S. A., & Brenner, M. B. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80109-9 · Cited by 49
Roach, T. I. A., Barton, C. H., Chatterjee, D., Liew, F. Y., & Blackwell, J. M. (1995) · PubMed Central · Cited by 46
Self-citationSynthesis of α 1→6-Mannooligosaccharides in Mycobacterium Smegmatis
Yokoyama, K., & Ballou, C. E. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)88230-1 · Cited by 42
Cited by
Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function
Geijtenbeek, T. B. H., van Vliet, S. J., Koppel, E. A., Sanchez-Hernandez, M., Vandenbroucke-Grauls, C. M. J. E., Appelmelk, B., & van Kooyk, Y. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021229 · Cited by 1,061
DC-SIGN: escape mechanism for pathogens
van Kooyk, Y., & Geijtenbeek, T. B. H. (2003) · Nature Reviews Immunology · doi:10.1038/nri1182 · Cited by 928
Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis
Brennan, P. J. (2003) · Tuberculosis · doi:10.1016/s1472-9792(02)00089-6 · Cited by 884
Skin microbiota–host interactions
Chen, Y. E., Fischbach, M. A., & Belkaid, Y. (2018) · Nature · doi:10.1038/nature25177 · Cited by 786
Modes of action of Freund's adjuvants in experimental models of autoimmune diseases
Billiau, A., & Matthys, P. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.6.849 · Cited by 617
Metadata
- Authors
- Chatterjee, D., & Khoo, K.-H.
- Venue
- Glycobiology
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-02-01
- Volume
- 8
- Issue
- 2
- Pages
- 113-120
- ISSN
- 0959-6658 (ISSN-L)
- 1460-2423
- OpenAlex
- W2167292122
- Cited by
- 351
- References
- 46
- FWCI
- 14.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.